Bladder Cancer

Posted on

Q) What is the most suitable treatment option for non muscle-invasive bladder cancer with the risk of recurrences? A)Cystectomy B)Intravesical chemotherapy C)Transurethral resection and adjuvant intravesical chemotherapy D)Palliative therapy Uro Onco MCQS

TNM Nasopharyngeal Carcinoma

Posted on
Surgery MCQs

Q ) 3.5cm mass in nasopharynx extending to left nasal cavity with 4.5cm size LN in supraclavicular area. staging, a.T1N1 B.T1N3 C.T2N1 D.T2N3

Pancreatic Fistula

Posted on

Q ) Post Whipple’s pancreatectomy drain amylase is done on ? (AIIMS ONCO) a) 1st day b) 3rd day c) 5th day d) Not required Onco Surgery AIIMS 2019 Q 21-40

Coronary vein

Posted on

Q) Coronary vein is  (AIIMS Onco 2019)  a) left gastric vein b) left gastroepiploic vein c) right gastric vein d) Right gastroepiploic Other Aiims onco MCQs              Onco 21-40    

Malignant polyp in colon

Posted on

Q ) Not a malignant polyp in colon (AIIMS Onco) a) Juvenile polyp b) Juvenile polyposis syndrome (JPS)  c) Peutz jeghers d) FAP

Bevacizumab

Posted on

Q) Not true about use of Bevacizumab (Free Ans) (Onco AIIMS)  a) It is a humanized monoclonal antibody against VEGF A b)  Bevacizumab is a first-line treatment in  metastatic nonsquamous non-small cell lung cancer.  c) Bevacizumab is a first-line or second-line therapy for metastatic colorectal cancer d) Its major advantage is that it has replaced combination chemotherapy    

Nasopharyngeal carcinoma

Posted on

Q) Not a true statement about nasopharyngeal Carcinoma? a) Type III has a better prognosis than Type I b) It commonly presents with blocked nose and upper neck mass c) Cranial nerves are commonly involved d) EBV is a causative agent AIIMS onco 2019 Onco Head and Neck